Previous close | 157.05 |
Open | 154.12 |
Bid | 174.30 |
Ask | 180.80 |
Strike | 260.00 |
Expiry date | 2025-01-17 |
Day's range | 154.12 - 157.05 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Moderna (MRNA) reachead $101.41 at the closing of the latest trading day, reflecting a -0.58% change compared to its last close.
Moderna stock is under pressure and estimates have come down for its first quarter. Is MRNA stock now a sell?
China's vaccine developers stuck with unused mRNA COVID shots and idle manufacturing plants are pursuing new targets for the novel messenger RNA technology, but they face a tough path, crimped by a lack of revenue. Three Chinese companies - Walvax Biotechnology, CSPC Pharmaceutical Group and Stemirna Therapeutics - came up with mRNA vaccines that won limited emergency approvals in Asia. However, Walvax and CSPC are not currently manufacturing three of their China market shots, a China health official told Reuters.